Novel Anti-B-Cell Therapy Looks Promising in MS

A new and novel oral therapy for multiple sclerosis, which inactivates rather than depletes B cells, has shown promising results in its first efficacy study.
Medscape Medical News

Source link

Related posts

Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders.


Reader response: The two lives of neurologist Helmut J. Bauer (1914-2008): Renowned MS specialist and National Socialist


Misophonia Explained: Signs and Symptoms of Selective Sound Sensitivity Syndrome


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World

WeCreativez WhatsApp Support
Our customer support team is here to answer your questions. Ask us anything!
👋 Hi, how can I help?